MCCULLOCH KEVIN

PrivateCIK: 2031695
Location

CHICAGO, IL

MCCULLOCH KEVIN (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderMCCULLOCH KEVINCIK 2031695
Officer· See Remarks
Since Mar 2026
+267.63K
Net shares
Net buyer
$927.8K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
393.69K acquired · 126.06K disposed
Non-Derivative Transactions4

Common Stock

Direct
A · Award

Shares

+168.46K

Price / share

Trade value

% of position

10.0%
1/30/2026
1.69M1.85M

Common Stock

Direct
F · Tax Withholding

Shares

68.45K

Price / share

$7.36

Trade value

$503.82K

% of position

3.7%
1/31/2026
1.85M1.79M

Common Stock

Direct
F · Tax Withholding

Shares

30.29K

Price / share

$7.36

Trade value

$222.93K

% of position

1.7%
1/31/2026
1.79M1.76M

Common Stock

Direct
F · Tax Withholding

Shares

27.32K

Price / share

$7.36

Trade value

$201.07K

% of position

1.6%
1/31/2026
1.76M1.73M
Total

Net shares

+42.40K

Net value

-$927.82K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

225.22K shares

Shares

+225.22K

Strike price

7.36

Held after

225.22K

Exercisable

1/30/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned25K
Total
25K indirect25K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
MCCULLOCH KEVIN — Insider Transaction (Form 4) Filed Feb 2, 2026 | Finecho